Nick Sheridan, Portfolio Manager at Janus Henderson released a report on small-cap stocks exploring how these stocks offer ...
The market has been a wild roller coaster ride these past five years. As the longest-running bull market hit new highs in ...
Biotech companies can skyrocket in a short period because of excellent clinical or regulatory progress. And if we take the ...
Bluebird bio (BLUE) shares continued their downward descent Monday following news that the company plans to be taken private through a deal valued at up to $96M. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results